These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 16183481)

  • 1. Radiotherapy for unresectable hepatic malignancies.
    Ben-Josef E; Lawrence TS
    Semin Radiat Oncol; 2005 Oct; 15(4):273-8. PubMed ID: 16183481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II trial of high-dose conformal radiation therapy with concurrent hepatic artery floxuridine for unresectable intrahepatic malignancies.
    Ben-Josef E; Normolle D; Ensminger WD; Walker S; Tatro D; Ten Haken RK; Knol J; Dawson LA; Pan C; Lawrence TS
    J Clin Oncol; 2005 Dec; 23(34):8739-47. PubMed ID: 16314634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiation therapy for intrahepatic malignancies.
    Quick AM; Lo SS; Mayr NA; Kim EY
    Expert Rev Anticancer Ther; 2009 Oct; 9(10):1511-21. PubMed ID: 19828012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Yttrium-90 labelled resin microspheres for treatment of primary and secondary malignant liver tumors.
    Van De Wiele C; Defreyne L; Peeters M; Lambert B
    Q J Nucl Med Mol Imaging; 2009 Jun; 53(3):317-24. PubMed ID: 19521311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiation therapy for hepatocellular carcinoma.
    Feng M; Ben-Josef E
    Semin Radiat Oncol; 2011 Oct; 21(4):271-7. PubMed ID: 21939856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-volumetric parameters predicting radiation-induced hepatic toxicity in unresectable hepatocellular carcinoma patients treated with three-dimensional conformal radiotherapy.
    Kim TH; Kim DY; Park JW; Kim SH; Choi JI; Kim HB; Lee WJ; Park SJ; Hong EK; Kim CM
    Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):225-31. PubMed ID: 17056199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Managing liver metastases with conformal radiation therapy.
    Topkan E; Onal HC; Yavuz MN
    J Support Oncol; 2008 Jan; 6(1):9-13, 15. PubMed ID: 18257395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conformal chemoradiation for primary and metastatic liver malignancies.
    Dawson LA; McGinn CJ; Lawrence TS
    Semin Surg Oncol; 2003; 21(4):249-55. PubMed ID: 14648782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiotherapy and hepatocellular carcinoma: update and review of the literature.
    Ursino S; Greco C; Cartei F; Colosimo C; Stefanelli A; Cacopardo B; Berretta M; Fiorica F
    Eur Rev Med Pharmacol Sci; 2012 Oct; 16(11):1599-604. PubMed ID: 23111978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Yttrium-90 radioembolization using TheraSphere in the management of primary and secondary liver tumors.
    Riaz A; Lewandowski RJ; Kulik L; Salem R
    Q J Nucl Med Mol Imaging; 2009 Jun; 53(3):311-6. PubMed ID: 19521310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Partial volume tolerance of the liver to radiation.
    Dawson LA; Ten Haken RK
    Semin Radiat Oncol; 2005 Oct; 15(4):279-83. PubMed ID: 16183482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment parameters and outcome in 680 treatments of internal radiation with resin 90Y-microspheres for unresectable hepatic tumors.
    Kennedy AS; McNeillie P; Dezarn WA; Nutting C; Sangro B; Wertman D; Garafalo M; Liu D; Coldwell D; Savin M; Jakobs T; Rose S; Warner R; Carter D; Sapareto S; Nag S; Gulec S; Calkins A; Gates VL; Salem R
    Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1494-500. PubMed ID: 19157721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiation dose limits and liver toxicities resulting from multiple yttrium-90 radioembolization treatments for hepatocellular carcinoma.
    Young JY; Rhee TK; Atassi B; Gates VL; Kulik L; Mulcahy MF; Larson AC; Ryu RK; Sato KT; Lewandowski RJ; Omary RA; Salem R
    J Vasc Interv Radiol; 2007 Nov; 18(11):1375-82. PubMed ID: 18003987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
    Tse RV; Hawkins M; Lockwood G; Kim JJ; Cummings B; Knox J; Sherman M; Dawson LA
    J Clin Oncol; 2008 Feb; 26(4):657-64. PubMed ID: 18172187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-volume histogram analysis of the safety of proton beam therapy for unresectable hepatocellular carcinoma.
    Kawashima M; Kohno R; Nakachi K; Nishio T; Mitsunaga S; Ikeda M; Konishi M; Takahashi S; Gotohda N; Arahira S; Zenda S; Ogino T; Kinoshita T
    Int J Radiat Oncol Biol Phys; 2011 Apr; 79(5):1479-86. PubMed ID: 20605350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The evolving role of radiation therapy in hepatocellular carcinoma.
    Dawson LA
    Cancer Radiother; 2008 Mar; 12(2):96-101. PubMed ID: 18289910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microsphere radioembolization of liver malignancies: current developments.
    Bult W; Vente MA; Zonnenberg BA; Van Het Schip AD; Nijsen JF
    Q J Nucl Med Mol Imaging; 2009 Jun; 53(3):325-35. PubMed ID: 19521312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiation therapy for hepatocellular carcinoma: from palliation to cure.
    Hawkins MA; Dawson LA
    Cancer; 2006 Apr; 106(8):1653-63. PubMed ID: 16541431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiation-induced liver disease in three-dimensional conformal radiation therapy for primary liver carcinoma: the risk factors and hepatic radiation tolerance.
    Liang SX; Zhu XD; Xu ZY; Zhu J; Zhao JD; Lu HJ; Yang YL; Chen L; Wang AY; Fu XL; Jiang GL
    Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):426-34. PubMed ID: 16690430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [External radiotherapy for hepatocellular carcinoma].
    Girard N; Mornex F
    Cancer Radiother; 2011 Feb; 15(1):49-53. PubMed ID: 21237691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.